What Precision’s regional leaders are really saying about global clinical development The signal was in the repetition. Across APAC this year, Precision for Medicine’s regional leaders have been in the rooms where global development strategy is being debated, from CMAC 2026 in Suzhou to Clinical Trials Festival Asia in Singapore to a China-based industry webinar. The topics kept changing: dose optimization , small-molecule differentiation, MRCT planning , and Australia’s early-phase role . The underlying concern did not.